Octagos vs Regard
Cardiology clinics with implanted device patients are the Octagos buyers. Octagos describes a two-step workflow, with Atlas AI analyzing each transmission first and an IBHRE-certified specialist finalizing, and a physician e-signature required on every report. Hospital clinical documentation and finance staff are the Regard buyers, wanting chart-wide diagnosis recommendations, each with an evidence chain according to the vendor.
Octagos reports 1 billion+ transmission pages processed and a 21-day average to EHR go-live. Regard reports 12,993,284 recommended diagnoses accepted by clinicians and shows Banner Health, Eisenhower Health and WakeMed on its homepage. All of these are vendor figures.
The openFDA 510(k) file holds nothing under Octagos, Octagos Health or Regard as applicant. Regard states audit logging on every assessment and data fetch, and Octagos states SOC 2 Type 2 and SOC 3 on Microsoft Azure. A hospital that runs both a device clinic and a documentation program would sign two contracts with two owners.
Decision support · Reviewed November 2, 2026

Octagos
by Octagos
Remote cardiac device monitoring where AI triages implantable device transmissions and US specialists review them, for cardiology clinics.

Regard
by Regard
AI platform that reviews the full EHR chart, suggests supported diagnoses with evidence, and drafts clinical notes for physician approval.
When to pick each one
Octagos
- IBHRE-certified specialist review of device transmissions
- Abbott, Medtronic, Boston Scientific devices, vendor-neutral claim
- 21 days average to EHR go-live, vendor says
Regard
- Diagnosis recommendations, vendor says each has evidence chain
- Banner Health and WakeMed shown as customers
Score
Each row shows points earned of points available under the published rubric.
Octagos
43of 100
Regard
9of 100
| Dimension | Octagos | Regard | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 2.8 / 5.6 | 1.7 / 5.6 | +1.1 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 4.8 / 4.8 | 1.9 / 4.8 | +2.9 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Octagos
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Regard
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Octagos
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
2 PubMed records name Octagos.
Regard
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Octagos | Regard |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, Oracle Health, athenahealth, medent, NextGen | Epic |
| Founded | n/a | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.
